Tuesday, December 13, 2022

Subcutaneous fat emerges as a protector of females’ brains

Peer-Reviewed Publication

MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY

Subcutaneous fat emerges as a protector of females’ brains 

IMAGE: DR. ALEXIS STRANAHAN view more 

CREDIT: MICHAEL HOLAHAN, AUGUSTA UNIVERSITY

AUGUSTA, Ga. (Dec. 13, 2022) – Females’ propensity to deposit more fat in places like their hips, buttocks and the backs of their arms, so-called subcutaneous fat, is protective against brain inflammation, which can result in problems like dementia and stroke, at least until menopause, scientists report.

Males of essentially any age have a greater propensity to deposit fat around the major organs in their abdominal cavity, called visceral adiposity, which is known to be far more inflammatory. And, before females reach menopause, males are considered at much higher risk for inflammation-related problems from heart attack to stroke.

“When people think about protection in women, their first thought is estrogen,” says Alexis M. Stranahan, PhD, neuroscientist in the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University. “But we need to get beyond the kind of simplistic idea that every sex difference involves hormone differences and hormone exposure. We need to really think more deeply about the underlying mechanisms for sex differences so that we can treat them and acknowledge the role that sex plays in different clinical outcomes.”

Diet and genetics are other likely factors that explain the differences broadly assigned to estrogen, says Stranahan, corresponding author of a study in the American Diabetes Association journal Diabetes.

She acknowledges that the findings are potentially heretical and revolutionary and certainly surprising even to her. “We did these experiments to try and nail down, first of all, what happens first, the hormone perturbation, the inflammation or the brain changes.”

To learn more about how the brain becomes inflamed, they looked at increases in the amount and location of fat tissue as well as levels of sex hormones and brain inflammation in male and female mice at different time intervals as they grew fatter on a high-fat diet.

Since, much like with people, obese female mice tend to have more subcutaneous fat and less visceral fat than male mice, they reasoned that the distinctive fat patterns might be a key reason for the protection from inflammation the females enjoy before menopause.

They found again the distinctive patterns of fat distribution in males and females in response to a high-fat diet. They found no indicators of brain inflammation or insulin resistance, which also increase inflammation and can lead to diabetes, until after the female mice reached menopause. At about 48 weeks, menstruation stops and fat positioning on the females starts to shift somewhat, to become more like males.

They then compared the impact of the high-fat diet, which is known to increase inflammation body wide, in mice of both sexes following surgery, similar to liposuction, to remove subcutaneous fat. They did nothing to directly interfere with normal estrogen levels, like removing the ovaries. 

The subcutaneous fat loss increased brain inflammation in females without moving the dial on levels of their estrogen and other sex hormones.

Bottom line: The females’ brain inflammation looked much more like the males’, including increased levels of classic inflammation promoters like the signaling proteins IL-1β and TNF alpha in the brain, Stranahan and her colleagues report. 

 “When we took subcutaneous fat out of the equation, all of a sudden the females’ brains start to exhibit inflammation the way that male brains do, and the females gained more visceral fat,” Stranahan says. “It kind of shunted everything toward that other storage location.” The transition occurred over about three months, which translates to several years in human time.

By comparison, it was only after menopause, that the females who did not have subcutaneous fat removed but did eat a high-fat diet, showed brain inflammation levels similar to the males, Stranahan says.

When subcutaneous fat was removed from mice on a low-fat diet at an early age, they developed a little more visceral fat and a little more inflammation in the fat. But Stranahan and her colleagues saw no evidence of inflammation in the brain.

One take-home lesson from the work: Don’t get liposuction and then eat a high-fat diet, Stranahan says. Another is: BMI, which simply divides weight by height and is commonly used to indicate overweight, obesity and consequently increased risk of a myriad of diseases, is likely not a very meaningful tool, she says. An also easy and more accurate indicator of both metabolic risk and potentially brain health, is the also easy-to-calculate waist to hip ratio, she adds.

“We can’t just say obesity. We have to start talking about where the fat is. That is the critical element here,” Stranahan says.

She notes that the new study looked specifically in the hippocampus and hypothalamus of the brain. The hypothalamus controls metabolism and exhibits changes with inflammation from obesity that help control conditions that develop bodywide as a result. The hippocampus, a center of learning and memory, is regulated by signals associated with those pathologies but doesn’t control them, Stranahan notes. While these are good places to start such explorations, other regions of the brain could respond very differently, so she is already looking at the impact of loss of subcutaneous fat in others. Also, since her evidence indicates estrogen may not explain the protection females have, Stranahan wants to better define what does. One of her suspects is the clear chromosomal differences between the XX female and the XY male.

Stranahan has been studying the impact of obesity on the brain for several years and is among the first scientists to show that visceral fat promotes brain inflammation in obese male mice, and, conversely, transplanting subcutaneous fat reduces their brain inflammation. Females also have naturally higher levels of proteins that can tamp down inflammation. It’s been shown that in males, but not females, microglia, immune cells in the brain, are activated by a high-fat diet.

She notes that some consider the reason that females have higher stores of subcutaneous fat is to enable sufficient energy stores for reproduction, and she is not challenging the relationship. But many questions remain like how much fat is needed to maintain fertility versus the level that will affect your metabolism, Stranahan says.

The research was supported by the National Institutes of Health.  

Read the study abstract.

VIDEO

Doctors give ineffective weight loss advice to patients with obesity

Peer-Reviewed Publication

OXFORD UNIVERSITY PRESS USA

A new research study published today in Family Practice, published by Oxford University Press, finds that when doctors tell patients living with obesity to lose weight the guidance they give is generally vague, superficial, and commonly not supported by scientific evidence.

Obesity is a chronic and relapsing condition, but physicians often lack guidance on which information is helpful for patients who would like to lose weight. As a result, the information patients receive can be hard to use and implement. Bad experiences are regularly reported by patients, who often see these conversations about weight as difficult.  

The researchers analyzed 159 audio recordings of consultations between general practitioners and patients living with obesity collected from the United Kingdom between 2013 and 2014. The investigation found that weight-loss advice from doctors to patients with obesity rarely included effective methods and mostly consisted of telling patients merely to eat less and be more physically active. The advice was mostly generic and rarely tailored to patients’ existing knowledge and behaviors, such as what strategies they had tried to lose weight before.  

The advice was mostly (97% of the time in analyzed consultations) abstract or general. Superficial guidance, such as one doctor telling a patient to just “change their lifestyle a bit” was common. Doctors gave patients information on how to carry out their advice in only 20% of the consultations. They mostly offered weight loss guidance without any detail about how to follow it. Doctors frequently (76% of the time in the consultations) told patients to get help somewhere else for support in weight loss, often suggesting that they return for another consultation at their surgery.

The analysis indicated that when doctors did offer specific information it was often scientifically unsupported and unlikely to result in actual weight loss. The notion that small changes in behavior (“take the stairs more often”) can have a large weight loss impact is a common myth and is even prevalent in scientific literature, but it isn’t supported by research. Another common myth was that patients just needed the “right mindset” to lose weight.

“This research demonstrates that doctors need clear guidelines on how to talk opportunistically to patients living with obesity about weight loss,” said one of the paper’s lead authors, Madeleine Tremblett. “This can help them to avoid amplifying stigmatizing stereotypes and give effective help to patients who want to lose weight."

The paper, “What advice do general practitioners give to people living with obesity to lose weight? A qualitative content analysis of recorded interactions,” is available (at midnight on December 13th) at: https://academic.oup.com/fampra/article-lookup/doi/10.1093/fampra/cmac137.

Direct correspondence to: 
Madeleine Tremblett
Nuffield Department of Primary Care Health Sciences
University of Oxford
Radcliffe Primary Care Building, Radcliffe Observatory Quarter
Woodstock Road, Oxford. OX2 6GG UNITED KINGDOM
madeleine.tremblett@phc.ox.ac.uk

To request a copy of the study, please contact:
Daniel Luzer 
daniel.luzer@oup.com

£2.4 million to fund largest-ever trial of ketamine-assisted therapy for alcohol disorder


A new £2.4 million phase III trial delivered across seven NHS sites across the UK will investigate whether ketamine-assisted therapy could help alcoholics stay off alcohol for longer.

Business Announcement

UNIVERSITY OF EXETER

A new £2.4 million phase III trial delivered across seven NHS sites across the UK will investigate whether ketamine-assisted therapy could help alcoholics stay off alcohol for longer.

Led by the University of Exeter, the new trial is being funded by the National Institute for Health and Care Research (NIHR) with additional funding from Awakn Life Sciences, a biotech company who specialise in researching and developing therapeutics to treat addiction.

The latest trial builds on a positive result of an earlier phase II trial, designed to test whether the treatment is safe. It showed ketamine and therapy treatment was safe and tolerable for people with severe alcohol use disorder. The earlier study found that participants who had ketamine combined with therapy stayed completely sober, representing 86 per cent abstinence in the six month follow-up. Now, the Ketamine for Reduction of Alcohol Relapse (KARE) trial will move to the next step of drug development, a phase III trial. It will test this promising finding further, with the aim of rolling it out into the NHS if it proves effective.

The trial will be run in conjunction with the NHS and the treatment will be provided in seven NHS sites across the UK. The trial will recruit 280 people with severe alcohol use disorder and participants will be randomly allocated to two arms. Half will be given ketamine at the dose used in the first clinical trial with psychological therapy. The other half will be given a very low dose of ketamine and a seven-session education package about the harmful effects of alcohol. Researchers will look at whether the ketamine and therapy package reduces harmful drinking.

Trial lead Professor Celia Morgan, from the University of Exeter, said: “More than two million UK adults have serious alcohol problems, yet only one in five of those get treatment. Three out of four people who quit alcohol will be back drinking heavily after a year. Alcohol-related harm is estimated to cost the NHS around £3.5 billion each year, and wider UK society around £40 billion. Alcohol problems affect not only the individual but families, friends and communities, and related deaths have increased still further since the pandemic. We urgently need new treatments. If this trial establishes that ketamine and therapy works, we hope we can begin to see it used in NHS settings.”

Professor Anne Lingford-Hughes, Professor of Addiction Biology at Imperial College London and Consultant Addiction Psychiatrist at Central North West London NHS Foundation Trust, said: “This is the largest trial of its kind in the world and builds on our earlier, smaller positive trial. We currently have few effective treatment options for people with alcoholism, and not all of these work for everyone. We desperately therefore need new treatments using different approaches such as this trial to help people regain control of their life and reduce the immense harms they experience from alcohol.”

Dr Stephen Kaar, one of the study leads of the University of Manchester, and Consultant Addictions Psychiatrist at Greater Manchester Mental Health NHS Foundation Trust, said: “Ketamine assisted psychotherapy for people with alcohol dependence offers the chance for a paradigm shift in how we treat this challenging and frequently re-occurring problem. 

“By bringing together the specific biochemical effects of ketamine and the supportive, structured and change focused space of psychotherapy, this study should finally establish the usefulness of this approach to treating addictions. 

“Ultimately, this study should lead to increased treatment options and improved outcomes for people with alcohol dependence, who at present have very few treatment options, when it comes to helping them stay sober or to develop a healthy relationship with alcohol after a detox.”

Awakn CEO Anthony Tennyson added “For this phase III to have the support and funding from the NIHR and for it to be delivered in the NHS is a great endorsement of this treatment’s potential and a sign of how badly a new more effective treatment is needed to help the millions of people suffering from Alcohol addiction in the UK. We are very proud to be part of this important piece of work.

The new trial will recruit participants across the following partner organisations: Imperial College London; Oxford Health NHS Trust; Greater Manchester Mental Health NHS Trust; Northern, Eastern, and Western Devon CCG; South London and Maudsley NHS Foundation Trust; the Exeter Clinical Trials Unit; Mersey Care NHS Trust; University College London Hospitals NHS Foundation Trust; NHS Forth Valley; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust. Recruitment will commence mid-way through 2023. To pre register interest in taking part, contact morekare@exeter.ac.uk

ENDS 

For further information:  

Louise Vennells

University of Exeter  

Press Office  

07768 511866

l.vennells@exeter.ac.uk   

EPIGENETICS

Meta-analysis reveals how crowds may change gene expression in some insects

Peer-Reviewed Publication

HIROSHIMA UNIVERSITY

Scatter plots of CI-score of all genes (2652 genes) identified in this study. 

IMAGE: THE HORIZONTAL AXIS INDICATES GENE RANKING BASED ON THE METHOD DEVELOPED IN OUR LABORATORY FOR THE META-ANALYSIS OF RNA-SEQUENCING DATA. THE VERTICAL AXIS SHOWS THE VALUES USED TO RANK GENES. HIGH-RANKING AND LOW-RANKING GENES INDICATE UPREGULATED GENES IN RESPONSE TO HIGH AND LOW DENSITIES, RESPECTIVELY. GENE NAMES ARE DESCRIBED NEXT TO PLOTS FOR PREVIOUSLY REPORTED DENSITY-RESPONSE GENES. IN ADDITION, THE GENES THAT HAVE NOT BEEN REPORTED AS DENSITY-RESPONSIVE GENES WERE ALSO INCLUDED IN HIGH-RANKING AND LOW-RANKING GENES. view more 

CREDIT: KOUHEI TOGA, HIROSHIMA UNIVERSITY

A grasshopper hatched in a crowded environment may look and behave differently than a grasshopper hatched in isolation — even if they have the same genes. The mechanism of this density-dependent phenomenon, called polyphenism, is well-documented in both aphids and locusts, but how genes regulate these traits has remained shrouded until now. Researchers from Hiroshima University analyzed datasets collected from prior studies to better understand how genes can influence one another to change their expression depending on environmental conditions. 

They published their results on Sept. 23 in Insects

“Aphids exhibit multiple wing types and locusts exhibit different body colors and behaviors,” said corresponding author Hidemasa Bono, professor in Hiroshima University’s Graduate School of Integrated Sciences for Life. “These well-known agricultural pests are representative of insects that exhibit density-dependent plasticity. To reveal the molecules common to all or multiple species that exhibit this same type of plasticity, we collected and reanalyzed publicly available RNA sequencing data of aphids and locusts.” 

The RNA sequencing data, called a transcriptome, is a collection of various expressed genes. It can also help identify new genes involved in producing specific traits. By performing a meta-analysis, researchers combine transcriptome results from multiple studies to see what the data says. In this study, the researchers analyzed 66 public transcriptome datasets from seven species of aphids and locusts.

“Meta-analysis is thought to be effective in providing additional insights into density-dependent polyphenism because it can uncover new information that would not be found with conventional hypothesis-driven research methods,” said first author Kouhei Toga, researcher in Hiroshima University’s Graduate School of Integrated Sciences for Life. “This study is the first meta-analysis conducted on datasets of two evolutionarily distant lineages, and it identified many density-responsive genes, which have scarcely been the focuses of research that aims to elucidate the molecular mechanisms of density-dependent plasticity.”

Specifically, the researchers found that DNA replication, DNA metabolic processes and the mitotic cell cycle were all enriched in response to crowded conditions. According to Toga, their results emphasize the importance of these processes— which have rarely been the focus of research in this area — as regulatory mechanisms in density-dependent polyphenism research. 

They also found discrepancies with some studies, including one that found a gene related to pigmentation in more gregarious locusts was more highly expressed in isolated conditions. When compared with the data from other studies, the researchers found the gene fit in a category of other genes that upregulated their expression when under oxidative stress. According to Bono, oxidative stress is a more likely explanation for the high gene expression in solitary locusts than in crowded conditions. 

“We also found neurological system modifications may play an important role in inducing density-dependent phenotypic changes in two lineages,” Bono said, explaining that several genes functioning in the nervous system, which would lead to density-dependent behavioral changes, increased under isolated conditions.

The findings can be generally applied to other species that exhibit density-dependent polyphenism due to the sheer amount of data from so many studies, which serves as a cross-check of previous hypotheses and results, according to Toga. 

“With increasing public RNA sequencing data, a meta-analysis that combines the data from multiple studies has succeeded in providing novel insights into targeted biological processes,” Toga said. “We hope that functional analysis of the genes identified in this study will lead to the development of methods to control the growth of aphids and locusts. We also hope to clarify how organisms respond and adapt to density by applying meta-analysis to various species.”

###

The Center for Innovation for Bio-Digital Transformation and the Japan Science and Technology Agency supported this research. Computations for this work were performed on the computers at the Hiroshima University Genome Editing Innovation Center.

About Hiroshima University

Since its foundation in 1949, Hiroshima University has striven to become one of the most prominent and comprehensive universities in Japan for the promotion and development of scholarship and education. Consisting of 12 schools for undergraduate level and 4 graduate schools, ranging from natural sciences to humanities and social sciences, the university has grown into one of the most distinguished comprehensive research universities in Japan.
English website: https://www.hiroshima-u.ac.jp/en

Trouble falling asleep at night? Chase that daytime light, study shows

Peer-Reviewed Publication

UNIVERSITY OF WASHINGTON

Overcast December day at the University of Washington 

IMAGE: AN OVERCAST DECEMBER DAY ON THE UNIVERSITY OF WASHINGTON CAMPUS IN SEATTLE. view more 

CREDIT: UNIVERSITY OF WASHINGTON

(Note: researcher contact information at the end)

 

A study measuring the sleep patterns of students at the University of Washington has turned up some surprises about how and when our bodies tell us to sleep — and illustrates the importance of getting outside during the day, even when it’s cloudy.

Published online Dec. 7 in the Journal of Pineal Researchthe study found that UW students fell asleep later in the evening and woke up later in the morning during — of all seasons — winter, when daylight hours on the UW’s Seattle campus are limited and the skies are notoriously overcast.

The team behind this study believes it has an explanation: The data showed that in winter students received less light exposure during the day. Other research has indicated that getting insufficient light during the day leads to problems at night, when it’s time for bed.

“Our bodies have a natural circadian clock that tells us when to go to sleep at night,” said senior author Horacio de la Iglesia, a UW professor of biology. “If you do not get enough exposure to light during the day when the sun is out, that ‘delays’ your clock and pushes back the onset of sleep at night.”

The study used wrist monitors to measure sleep patterns and light exposure for 507 UW undergraduate students from 2015 to 2018. Data indicated that students were getting roughly the same amount of sleep each night regardless of season. But, on school days during the winter, students were going to bed on average 35 minutes later and waking up 27 minutes later than summer school days. This finding surprised the team, since Seattle — a high-latitude city — receives nearly 16 hours of sunlight on the summer solstice, with plenty evening light for social life, and just over eight hours of sunlight on the winter solstice.

“We were expecting that in the summer students would be up later due to all the light that’s available during that season,” said de la Iglesia.

Based on student sleep data, the researchers hypothesized that something in winter was “pushing back” the students’ circadian cycles. For most humans, including college students, the innate circadian cycle governing when we’re awake and asleep runs at about 24 hours and 20 minutes — and is “calibrated” daily by input from our environment. For UW students in the study, sleep data indicated that their circadian cycles were running up to 40 minutes later in winter compared to summer.

The team focused on light as a potential explanation for this winter delay. But light has different impacts on circadian rhythms at different times of the day.

“Light during the day — especially in the morning — advances your clock, so you get tired earlier in the evening, but light exposure late in the day or early night will delay your clock, pushing back the time that you will feel tired,” said de la Iglesia. “Ultimately, the time that you fall asleep is a result of the push and pull between these opposite effects of light exposure at different times of the day.”

Data showed that daytime light exposure had a greater impact than evening light exposure in the UW study. Each hour of daytime light “moved up” the students’ circadian phases by 30 minutes. Even outdoor light exposure on cloudy or overcast winter days in Seattle had this effect, since that light is still significantly brighter than artificial indoor lighting, said de la Iglesia. Each hour of evening light — light from indoor sources like lamps and computer screens — delayed circadian phases by an average of 15 minutes.

“It’s that push-and-pull effect,” said de la Iglesia. “And what we found here is that since students weren’t getting enough daytime light exposure in the winter, their circadian clocks were delayed compared to summer.”

The study offers lessons not just for college students. 

“Many of us live in cities and towns with lots of artificial light and lifestyles that keep us indoors during the day,” said de la Iglesia. “What this study shows is that we need to get out — even for a little while and especially in the morning — to get that natural light exposure. In the evening, minimize screen time and artificial lighting to help us fall asleep.”

Lead author on the paper is Gideon Dunster, an associate manager with the Allen Institute for Cell Science, who conducted the study as a UW doctoral student. Co-authors are UW undergraduate alum Isabelle Hua, now a researcher at the National Institute of Neurological Disorders and Stroke; Alex Grahe in the UW Department of Biology; Jason Fleischer and Satchidananda Panda of the Salk Institute; Kenneth Wright and Céline Vetter of the University of Colorado, Boulder; and UW teaching professor of biology Jennifer Doherty. The research was funded by the National Science Foundation. Dunster was supported by the Riddiford-Truman Fellowship and the Hoag Endowed Graduate Fellowship through the UW Department of Biology.

###

For more information, contact Horacio de la Iglesia at horaciod@uw.edu.

Grant number: 1743364

Life and death of an "altruistic" bacterium

Peer-Reviewed Publication

UNIVERSITY OF MONTREAL

Fluorescent Biofilm 

IMAGE: FLUORESCENCE IMAGE OF A CAULOBACTER BIOFILM. LIVE CELLS ARE LABELLED IN GREEN, DEAD ONES IN PINK, AND EXTRACELLULAR DNA RELEASE DURING CELL DEATH IS SHOWN IN BLUE. view more 

CREDIT: CÉCILE BERNE, UNIVERSITÉ DE MONTRÉAL

Biofilms, complex communities of bacteria, abound around us: on the surface of cheese where they give off flavors and aromas, in streams where they form the slimy substance on rocks, on our teeth where they form plaque.

Living in a biofilm provides numerous advantages to bacteria: things like resource sharing, shelter from predators, and increased resistance to toxic compounds such as antibiotics.

But having the option to leave the biofilm when environmental conditions deteriorate can be a plus for bacteria, too, allowing them to relocate to a more hospitable environment.

‘’For the bacterium Caulobacter crescentus, the biofilm becomes a kind of prison in perpetuity: once cells are attached to a surface through a strong adhesive at one end of the cell, they cannot leave the biofilm,” said Yves Brun, a professor in the Department of Microbiology, Infectious Diseases and Immunology at Université de Montréal.

‘’However, when these attached cells divide, their unattached ‘daughter’ cells have a choice of joining the biofilm or swimming away.’’

Cells release their DNA

How do cells decide to stay or leave the biofilm? ‘’We showed in a study published in 2010  that when Caulobacter cells die in the biofilm, they release their DNA, which inhibits daughter cells from joining the biofilm, hence promoting relocation from environments where death rate increases,’’  Brun said.

He and his research team therefore wanted to determine if cell death occurred randomly as the environmental quality declined or if it was a regulated process responding to a specific signal.

‘’We showed that Caulobacter uses a programmed cell death mechanism that causes some cells to sacrifice themselves when the conditions inside the biofilm deteriorate,” said team member Cécile Berne, the lead author of the study.

‘’Known as a toxin-antitoxin system, this mechanism uses a toxin that targets a vital function and its associated antidote, the antitoxin,” she said. “The toxin is more stable than the antitoxin and when programmed cell death is initiated, the amount of antitoxin is reduced, resulting in cell death.’’

When oxygen becomes sparse

‘’Using a combination of genetics and microscopy, we showed that the toxin-antitoxin system is activated when oxygen becomes sparse as the biofilm becomes larger and cells compete for the available oxygen,’’ Berne added.

The resulting death of a subset of cells releases DNA, which promotes the dispersal of their live siblings to potentially more hospitable environments, thereby preventing overcrowding that would further reduce environmental quality in the biofilm.

Biofilms have both positive and negative impacts on our everyday life. Bacteria living in biofilms are commonly used in food production, wastewater treatment, and pollution remediation.

‘’The downside is that the biofilm lifestyle is also a strategy used by pathogenic bacteria to become more resistant to antibiotics,” said Brun.

“Understanding the mechanisms driving the balance between cells joining the biofilm and cells  swimming away will help us develop solutions to the challenge of antibiotic resistance, to promote the formation of biofilms when we want them, and eradicate them when we do not.’’

About this study

eDNA-stimulated cell dispersion from Caulobacter crescentus biofilms upon oxygen limitation is dependent on a toxin-antitoxin system” by Cécile Berne, Sébastien Zappa and Yves Brun was published in eLife on December 7, 2022.

  

A mature bacterial film (biofilm) of Caulobacter cells attached to a glass surface.

Attached Caulobacter cells forming a biofilm around a dust particle.

CREDIT

Cécile Berne, Université de Montréal


School-age health at heart of University of Huddersfield and UNESCO Chair project

Business Announcement

UNIVERSITY OF HUDDERSFIELD

Professor Didier Jourdan and Dr Nicola Gray 

IMAGE: PROFESSOR DIDIER JOURDAN AND DR NICOLA GRAY view more 

CREDIT: UNIVERSITY OF HUDDERSFIELD

Improving the health of children and young people through creative collaborations between health and education professionals will be the focus of the University of Huddersfield’s input into the UNESCO Chair ‘Global Health and Education’ for the period 2022-2026. The university is co-chair holder together with the University of Clermont Auvergne in France.

The University’s co-chair holder of the second four-year mandate of the UNESCO Chair is Dr Nicola Gray, Senior Lecturer in Pharmacy Practice. A Trustee of the UK Association for Young People's Health  and a Fellow of the US Society for Adolescent Health and Medicine, Dr Gray has worked closely with UNESCO and partner institution the University of Clermont Auvergne.

The UNESCO Chair ‘Global Health and Education’ was founded in 2018 by leading global experts in the field of school health promotion in Clermont Auvergne’s Professor Didier Jourdan, who is also Visiting Professor in Public Health at Huddersfield, and Goof Buijs, former manager of the SHE (Schools for Health in Europe) network, two leading global experts in the field of school health promotion. Dr Gray became involved through her role as the Vice President for Europe at the International Association for Adolescent Health (IAAH).

“We are giving technical advice to UNESCO and other UN agencies,” says Dr Gray. “It is a two-way channel - with various initiatives we will try to influence and give technical input into UNESCO’s plans, while they will share events and documents with us that we will disseminate to our networks. 

The start of the second four-year mandate of the UNESCO Chair coincides with the 30th anniversary of the global UNESCO Chair/UNITWIN Programme of UNESCO, the network that sees institutions like Huddersfield and Clermont Auvergne pooling resources and sharing their knowledge inside and outside academia. The Chair is building a global community connecting universities, public and private organisations and individuals. This community can get involved with knowledge production, capacity-building and knowledge-sharing activities.

Integrating health into the journey through school and beyond is one of the flagship programmes of the current term of the UNESCO Chair, according to Professor Jourdan.

“The traditional approach to health at schools has been visits by health professionals to give out vaccinations or speak to pupils. The changes we are looking at are more sustained, where health and awareness of health issues are threaded through the school calendar and curriculum, rather than on specific occasions. Health promotion can be seen as an extra that is ‘parachuted’ in and becomes a burden, but we’d like teachers to see it as an extra skill and a source of pride.

“This is coinciding with a number of UN initiatives, like the launch of global standards and indicators to make every school a health-promoting school. The importance of health in schools became a real focus during the worst of the COVID-19 pandemic. I have been a member of the WHO Europe Technical Advisory Group (TAG) on Safe Schooling during the COVID-19 pandemic, giving input on how the education and the health sectors can better work together”.

Dr Gray adds: “We feel that health professionals partnering with schools can give children vital life skills. How to look after yourself, looking after your health and relationships, being able to express feelings, how to interact with others, knowing how the body works, how important it is to eat well – addressing all these issues at a young age could have a positive impact in the long term.

“The operational team for the UNESCO Chair at Huddersfield includes experts from the Schools of Applied Sciences, Education and Professional Development, Human and Health Sciences and Huddersfield Business School. This multidisciplinary approach reflects the links that we will make through our networks to individuals and organisations at local, national and international level.”

The connection between illnesses of the digestive and nervous systems

New DFG research unit to research the “gut-brain axis”

Grant and Award Announcement

FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NÜRNBERG

How do the gut and the brain interact, and can this even trigger disease? There is growing consensus within the research community that the nervous and digestive systems interact with each other. How exactly, however, is still largely unknown. The German Research Foundation (DFG) is now funding a new clinical research unit at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) that will investigate the interaction between the digestive and nervous systems with reference to inflammatory and degenerative diseases, the first collaborative research group in Germany to explore the “gut-brain axis”. The interdisciplinary team will receive a total of 6 million euros of funding over the coming four years.

For several years now, medical research has become increasingly fascinated by the buzzword “gut-brain axis”. This refers to the assumption that there is a connection between neurological diseases and immunological changes in the gastrointestinal tract, in other words that the gut and the brain interact, and that as a result of this interaction, diseases in either system may mutually affect each other or even act as a trigger for the disease in the first place. Studies show that patients with chronic inflammatory bowel diseases (IBD) have a greater risk of developing Parkinson’s disease later in life. Or that there may be a connection between multiple sclerosis and IBD.

The interaction is controlled by a highly complex communication system involving neural, hormonal, metabolic, immunological and microbial signals. The newly established clinical DFG research unit 5024 “Immune checkpoints of gut-brain communication in inflammatory and neurodegenerative diseases” led by Prof. Dr. Claudia Günther, FAU professor of gastrointestinal pathophysiology, and speaker Prof. Dr. Beate Winner, head of the Department of Stem Cell Biology at Universitätsklinikum Erlangen, will investigate what exactly this communication involves. The new research field is characterized not only by the close interdisciplinary collaboration between immunology, gastroenterology and neurosciences, but also by the integration of bioinformatics and machine learning as well as medical engineering.

Over the coming years, the researchers hope first of all to obtain more specific insights into the interaction between the gut and the brain in inflammatory and degenerative diseases and to decode immunological switches in communication between the gut and the brain. Building on these findings, they then hope to develop new approaches for treatment aimed at fighting or even preventing diseases of the digestive and nervous systems.

About DFG research units

Research units (RU) are groups of several researchers based at one or more locations. They often contribute to establishing new areas of research. The aim of a clinical research unit (CRU) is to promote research groups involved in disease or patient-oriented (translational) clinical research and set up permanent research groups in clinical facilities.

Overview of all DFG research units at FAU